Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk

NCT02028221 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

151

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer Prevention

Interventions

DRUG: Metformin
DRUG: Placebo

Sponsor

University of Arizona

Collaborators

[object Object]